NYSE:C

AI Revolution: 48 Hours of Breakthroughs, Battles, and Backlash (July 17–18, 2025)

OpenAI launched ChatGPT Agent on July 17, enabling the chatbot to take actions like booking reservations and connecting to apps, with user confirmation required. Amazon introduced Bedrock AgentCore and a $100 million AI fund at AWS Summit New York. Meta formed Superintelligence Labs and confirmed new AI hires. The European Commission said the AI Act will apply to major models from August 2, with fines up to €35 million for violations.

18 July 2025

Innovation·NASDAQ:AMZN·NASDAQ:GOOGL·NASDAQ:META·NASDAQ:MSFT·NYSE:C·Technology

RegTech Roundup: Key Regulatory Compliance Tech Developments (June–July 2025)

The European Commission adopted new liquidity standards for stablecoins under MiCA on June 27, 2025. The U.S. SEC launched a Crypto Task Force July 1. UK-based CUBE acquired Acin, expanding its controls platform to 1,000 clients. Zango AI raised $4.8 million to develop regulation-specific LLMs for banks including Novobanco and Monzo.

8 July 2025

EPA:BNP·LSE:BARC·LSE:LLOY·NYSE:C·NYSE:JPM·Technology

Previous 1 … 9 10 11

Becton Dickinson (BDX) Stock Seen Undervalued Amid Recent Price Declines
March 14, 2026, 1:04 PM EDT. Becton Dickinson's shares dropped 4.6% last week and 18.3% year to date, sparking questions about its market valuation. A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of $218.65 per share, indicating the stock is trading roughly 27.1% below fair value. The company's latest free cash flow stands at $2.60 billion, with analyst forecasts projecting growth to $3.73 billion by 2030. Becton Dickinson's price-to-earnings (P/E) ratio of 25.83 is near the Medical Equipment industry average, reflecting current investor expectations. These metrics suggest a potential buying opportunity for long-term investors watching shifts in healthcare supplier valuations.